What is Meliora?
Founded in 2021 and headquartered in Menlo Park, CA, Meliora is a biotechnology company dedicated to the research and development of oncology drugs. The company's focus on cancer therapeutics positions it within a critical and rapidly evolving sector of the pharmaceutical industry. Meliora aims to address unmet needs in cancer treatment through innovative scientific approaches and a robust drug discovery platform. The recent influx of capital is expected to accelerate its research initiatives and clinical trials.
How much funding has Meliora raised?
Meliora has raised a total of $11M across 1 funding round:
Angel/Seed
$11M
Angel/Seed (2022): $11M with participation from villageglobal.com, BrightEdge, ZhenFund, HOF Capital, Pebblebed, and The Obvious
Key Investors in Meliora
villageglobal.com
Village Global VC is an early-stage venture capital firm that supports startups with funding, mentorship, and access to a network of successful entrepreneurs and investors. They invest between $500K and $3M in pre-seed and seed rounds globally, focusing on resourceful founders across various sectors.
BrightEdge
BrightEdge is an enterprise SEO marketing company that transforms online content into tangible business results, like traffic, engagement, and revenue. BrightEdge's SEO platform is powered by a sophisticated AI and machine learning engine.
ZhenFund
ZhenFund is an angel investment firm that focuses on supporting innovative entrepreneurs and startups. They believe in the rarity and value of good entrepreneurs who can identify promising business directions and create effective products.
What's next for Meliora?
With the recent major strategic investment, Meliora is poised for significant expansion and advancement in its oncology drug development programs. The company is likely to leverage this capital to scale its research operations, conduct further preclinical and clinical studies, and potentially expand its team of scientists and researchers. This funding round suggests strong investor confidence in Meliora's technology and its potential to bring impactful cancer treatments to market, positioning the company for future growth and strategic partnerships within the biotechnology sector.
See full Meliora company page
